Details:

Personal Author:
Shimabukuro, Tom T. ; Mbaeyi, Sarah A.
Shimabukuro, Tom T. ; Mbaeyi, Sarah A. Less -
Corporate Authors:
National Center for Preparedness, Detection, and Control of Infectious Diseases (U.S.). Clinician Outreach and Communication Activity. ; CDC COVID-19 Response Team.
National Center for Preparedness, Detection, and Control of Infectious Diseases (U.S.). Clinician Outreach and Communication Activity. ; CDC COVID-19 Response Team. Less -
Description:
Date: Wednesday, December 30, 2020

Time: 2:00 PM – 3:00 PM ET

During this COCA call, clinicians will give an overview of recommendations for use of COVID-19 vaccines in certain populations. Clinicians will learn more about the recent reports of anaphylaxis following vaccination, as well as CDC’s updated clinical considerations around contraindications and precautions to vaccination.

dec-30-coca-call.pdf


Content Notes:
Anaphylaxis following mRNA COVID-19 vaccination / Tom Shimabukuro -- Contraindications and Precautions to mRNA COVID-19 vaccination.
Subject:
[+]
Coronavirus Infections/prevention & Control
COVID-19
COVID-19 Vaccines
COVID-19 Vaccines/adverse Effects
Hypersensitivity
Patient Safety
Viral Vaccines

Series:
Clinician Outreach and Communication Activity (COCA) Webinar
Document Type:
Presentation
Genre:
Webcasts
Collection(s):
Stephen B. Thacker CDC Library collection
Main Document Checksum:
[+]
urn:sha256:db1e856e0386182be129229575baeed340d7165aab6b045feec9cf6c9b55a80b
File Type:

Supporting Files

• 	callinfo_123020.asp	htm
  	12_30_2020_coca_call.mp4	mp4

More +